The management of diabetic retinopathy (DR) has evolved considerably over the past
decade, with the availability of new technologies (diagnostic and therapeutic). As such, the …

Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract
surgery, leading in some cases to a decrease in vision. Although the pathogenesis of PCME …

The number of eye diseases treated with intravitreal injections is increasing. Obviously, an
injection of fluid into the eye results in an increase of intraocular pressure (IOP), the main …

Management of center-involving diabetic macular edema represents a real therapeutic
challenge. Diabetic macular edema is the leading cause of visual acuity impairment in …

Pseudophakic cystoid macular oedema (PCMO) remains a significant cause of
compromised postoperative vision in contemporary cataract surgery. Well‐established risk …

Purpose: To analyze the incidence, risk factors, and time to onset of ocular hypertension
(OHT) after intravitreal injections (IVI) of dexamethasone implant and to evaluate the long …

Irvine–Gass syndrome (IGS) remains one of the most common complications following
uneventful cataract surgery. In most cases, macular edema (ME) in IGS is benign, self …

Inflammation after the cataract surgery can be prevented, and these methods are one of the
most essential topics with growing phacoemulsification rate. Topical NSAIDs are cost …

Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe
for the treatment of macular edema related to diabetic retinopathy, branch retinal vein …

Purpose: To report the outcomes of the 0.18 mg fluocinolone acetonide insert (FAi) in the
treatment of chronic (> 6 months) postoperative cystoid macular edema after cataract …